Medical Dialogues
  • Dermatology
Login Register
This site is intended for healthcare professionals only
Login Register
  • MD Brand Connect
  • MDTV
    • Breaking News
    • Medical News Today
    • Health News Today
    • Latest
    • Journal Club
    • Medico Legal Update
    • Latest Webinars
    • MD Shorts
    • Health Dialogues
Medical Dialogues
  • Medical News & Guidelines
      • Anesthesiology
      • Cardiology and CTVS
      • Critical Care
      • Dentistry
      • Dermatology
      • Diabetes and Endocrinology
      • ENT
      • Gastroenterology
      • Medicine
      • Nephrology
      • Neurology
      • Obstretics-Gynaecology
      • Oncology
      • Ophthalmology
      • Orthopaedics
      • Pediatrics-Neonatology
      • Psychiatry
      • Pulmonology
      • Radiology
      • Surgery
      • Urology
      • Laboratory Medicine
      • Diet
      • Nursing
      • Paramedical
      • Physiotherapy
  • Health news
      • Doctor News
      • Government Policies
      • Hospital & Diagnostics
      • International Health News
      • MCI News
      • Medical Organization News
      • Medico Legal News
      • NBE News
      • NMC News
  • AYUSH
    • Ayurveda
    • Homeopathy
    • Siddha
    • Unani
    • Yoga
  • State News
      • Andaman and Nicobar Islands
      • Andhra Pradesh
      • Arunachal Pradesh
      • Assam
      • Bihar
      • Chandigarh
      • Chattisgarh
      • Dadra and Nagar Haveli
      • Daman and Diu
      • Delhi
      • Goa
      • Gujarat
      • Haryana
      • Himachal Pradesh
      • Jammu & Kashmir
      • Jharkhand
      • Karnataka
      • Kerala
      • Ladakh
      • Lakshadweep
      • Madhya Pradesh
      • Maharashtra
      • Manipur
      • Meghalaya
      • Mizoram
      • Nagaland
      • Odisha
      • Puducherry
      • Punjab
      • Rajasthan
      • Sikkim
      • Tamil Nadu
      • Telangana
      • Tripura
      • Uttar Pradesh
      • Uttrakhand
      • West Bengal
  • Medical Education
      • Ayush Education News
      • Dentistry Education News
      • Medical Admission News
      • Medical Colleges News
      • Medical Courses News
      • Medical Universities News
      • Nursing education News
      • Paramedical Education News
      • Study Aborad
  • Industry
      • Health Investment News
      • Health Startup News
      • Medical Devices News
      • Pharma News
      • Pharmacy Education News
      • Industry Perspective
  • MDTV
      • Health Dialogues MDTV
      • Health News today MDTV
      • Latest Videos MDTV
      • Latest Webinars MDTV
      • MD shorts MDTV
      • Medical News Today MDTV
      • Medico Legal Update MDTV
      • Top Videos MDTV
      • Health Perspectives MDTV
      • Journal Club MDTV
      • Medical Dialogues Show
This site is intended for healthcare professionals only
LoginRegister
Medical Dialogues
LoginRegister
  • Home
  • Medical news & Guidelines
    • Anesthesiology
    • Cardiology and CTVS
    • Critical Care
    • Dentistry
    • Dermatology
    • Diabetes and Endocrinology
    • ENT
    • Gastroenterology
    • Medicine
    • Nephrology
    • Neurology
    • Obstretics-Gynaecology
    • Oncology
    • Ophthalmology
    • Orthopaedics
    • Pediatrics-Neonatology
    • Psychiatry
    • Pulmonology
    • Radiology
    • Surgery
    • Urology
    • Laboratory Medicine
    • Diet
    • Nursing
    • Paramedical
    • Physiotherapy
  • Health news
    • Doctor News
    • Government Policies
    • Hospital & Diagnostics
    • International Health News
    • MCI News
    • Medical Organization News
    • Medico Legal News
    • NBE News
    • NMC News
  • AYUSH
    • Ayurveda
      • Ayurveda Giuidelines
      • Ayurveda News
    • Homeopathy
      • Homeopathy Guidelines
      • Homeopathy News
    • Siddha
      • Siddha Guidelines
      • Siddha News
    • Unani
      • Unani Guidelines
      • Unani News
    • Yoga
      • Yoga Guidelines
      • Yoga News
  • State News
    • Andaman and Nicobar Islands
    • Andhra Pradesh
    • Arunachal Pradesh
    • Assam
    • Bihar
    • Chandigarh
    • Chattisgarh
    • Dadra and Nagar Haveli
    • Daman and Diu
    • Delhi
    • Goa
    • Gujarat
    • Haryana
    • Himachal Pradesh
    • Jammu & Kashmir
    • Jharkhand
    • Karnataka
    • Kerala
    • Ladakh
    • Lakshadweep
    • Madhya Pradesh
    • Maharashtra
    • Manipur
    • Meghalaya
    • Mizoram
    • Nagaland
    • Odisha
    • Puducherry
    • Punjab
    • Rajasthan
    • Sikkim
    • Tamil Nadu
    • Telangana
    • Tripura
    • Uttar Pradesh
    • Uttrakhand
    • West Bengal
  • Medical Education
    • Ayush Education News
    • Dentistry Education News
    • Medical Admission News
    • Medical Colleges News
    • Medical Courses News
    • Medical Universities News
    • Nursing education News
    • Paramedical Education News
    • Study Aborad
  • Industry
    • Health Investment News
    • Health Startup News
    • Medical Devices News
    • Pharma News
      • CDSCO (Central Drugs Standard Control Organisation) News
    • Pharmacy Education News
    • Industry Perspective
  • Home
  • Critical Care
  • Critical Care News
  • Transfusion of...

Transfusion of convalescent plasma promises mortality benefits in immunocompromised COVID-19 patients

AditiWritten by Aditi Published On 2023-01-17T20:00:01+05:30  |  Updated On 17 Jan 2023 2:30 PM GMT
Transfusion of convalescent plasma promises mortality benefits in immunocompromised COVID-19 patients
  • facebook
  • twitter
  • linkedin
  • whatsapp
  • Telegram
  • koo
  • Email

Mayo Clinic: A recent Original Investigation for Infectious Diseases published in JAMA Network Open has mentioned that convalescent plasma is tied to mortality benefits to hospitalised patients with primary or secondary immunosuppression and COVID-19.Immunocompromised patients have a higher risk for morbidity and mortality associated with COVID-19. They mount antibody responses...

Mayo Clinic: A recent Original Investigation for Infectious Diseases published in JAMA Network Open has mentioned that convalescent plasma is tied to mortality benefits to hospitalised patients with primary or secondary immunosuppression and COVID-19.

Immunocompromised patients have a higher risk for morbidity and mortality associated with COVID-19. They mount antibody responses less frequently to vaccines. To treat COVID-19, neutralizing anti-spike monoclonal-antibody treatment has been used, but evolutions of SARS-CoV-2 have been related to monoclonal antibody-resistant SARS-CoV-2 variants and greater virulence and transmissibility of SARS-CoV-2. COVID-19 convalescent plasma has increased therapeutically based on the presumption that plasma contains antibodies to SARS-CoV-2, which are potentially therapeutic and can be transferred passively to the recipient.

What is the pooled evidence in this context?

Investigating further, a researchers team did a study to assess the growing reports of clinical experiences of COVID-19 immunocompromised patients treated with COVID-19 convalescent plasma transfusion. The lead researcher was Jonathon W.Senefeld, PhD. The study points are:

• The researchers selected relevant RCTs, matched cohort studies, and case reports or series

• Four hundred sixty-two unique records were yielded in the electronic search, and 199 were considered for full-text screening.

• All-cause mortality after COVID-19 convalescent plasma transfusion was the prespecified endpoint.

• The exploratory subgroup analyses were based on putative factors related to the potential mortality benefit of convalescent plasma.

• The review and meta-analysis included the following:

 3 RCT enrolled 1487 participants.

 Five matched cohort studies

 13 uncontrolled large case series enrolled 358 participants.

 125 case report series enrolled 265 participants.

• Transfusion of COVID-19 convalescent plasma decreased mortality than the control cohort for the amalgam of both RCT and matched cohort studies having a risk ratio [RR] of 0.63

To conclude, the researchers encourage using therapeutic convalescent plasma in COVID-19 patients with immunosuppression (primary or secondary); there remains a lack of well-controlled, published data in these important patient populations.

Further investigations are warranted in this context.

Further reading:

Senefeld JW et al. COVID-19 Convalescent Plasma for the Treatment of Immunocompromised Patients: A Systematic Review and Meta-analysis. doi:10.1001/jamanetworkopen.2022.50647

COVID-19 convalescent plasmaimmunocompromised patientsJAMAJAMA Network OpenCOVID-19
Source : JAMA Network Open
Aditi
Aditi

    BDS,MDS in Periodontics and Implantology

    Dr. Aditi Yadav is a BDS, MDS in Periodontics and Implantology. She has a clinical experience of 5 years as a laser dental surgeon. She also has a Diploma in clinical research and pharmacovigilance and is a Certified data scientist. She is currently working as a content developer in e-health services. Dr. Yadav has a keen interest in Medical Journalism and is actively involved in Medical Research writing.

    Show Full Article
    Next Story
    Similar Posts
    NO DATA FOUND

    Editorial

    Journal Club Today

    Health News Today

    © 2022 All Rights Reserved.
    Powered By: Hocalwire
    X